Patent ID: 11970496
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. A method of treating a cancer in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of a compound selected from the group consisting of:
4-((3-chlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (1),
4-(m-tolylamino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (2),
4-((3-methoxyphenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (3),
4-((3-(dimethylamino)phenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (4),
4-((3,5-dimethylphenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (5),
4-((3,5-dichlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (6),
4-((4-chlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (7),
4-(p-tolylamino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (8),
4-((4-(N,N-dimethylsulfamoyl)phenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (9),
4-((2-methylpyridin-4-yl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (10),
4-((3-chlorobenzyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (11), and
4-((3-(dimethylamino)propyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (12),
or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof,
wherein the cancer is one or more selected from the group consisting of leukemia, melanoma, colon cancer, prostate cancer, pancreatic cancer, and breast cancer.